Addus HomeCare Corporation (ADUS) stock analysis
ADUS · Addus HomeCare Corporation
Latest recorded price: USD 124.61
Model-estimated fair value: USD 93.72. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Care Facilities
At $124.61, ADUS trades 33.0% above the model's base-case value of $93.72. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $72.62 in the conservative case and $120.01 in the optimistic case, with a valuation confidence score of 81/100. About 78% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 14.4%, free cash flow margin 7.3%, ROIC 10.9%. The model flags 1 risk signal for this company.